{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:58:54Z","timestamp":1780883934350,"version":"3.54.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-026-00680-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:46:30Z","timestamp":1777031190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A continuous viral vaccine biomanufacturing platform utilizing multiple bioreactor configurations"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6734-3510","authenticated-orcid":false,"given":"Justin","family":"Sargunas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2849-6119","authenticated-orcid":false,"given":"Bradley","family":"Priem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Carman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taravat","family":"Sarvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-2285","authenticated-orcid":false,"given":"Natalie M.","family":"Nold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-314X","authenticated-orcid":false,"given":"Vaishali","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-1761","authenticated-orcid":false,"given":"Andrew","family":"Pekosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0776-8763","authenticated-orcid":false,"given":"Caryn L.","family":"Heldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-4659","authenticated-orcid":false,"given":"Michael","family":"Betenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"680_CR1","doi-asserted-by":"publisher","unstructured":"Bell DM, Weisfuse IB, Hernandez-Avila M, Rio CD, Bustamante X, Rodier G. Pandemic influenza as 21st Century Urban Public health crisis. Emerg Infect Dis. 1963, Dec. 2009;15(12). https:\/\/doi.org\/10.3201\/EID1512.091232.","DOI":"10.3201\/EID1512.091232"},{"issue":"39\u201340","key":"680_CR2","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1016\/J.VACCINE.2007.07.027","volume":"25","author":"F Carrat","year":"2007","unstructured":"Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007, Sep;25(39\u201340):6852\u201362. https:\/\/doi.org\/10.1016\/J.VACCINE.2007.07.027.","journal-title":"Vaccine"},{"key":"680_CR3","doi-asserted-by":"publisher","unstructured":"Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005, Aug. 2005;8(8(3: , 3):591\u2013600. https:\/\/doi.org\/10.1038\/nrmicro1208.","DOI":"10.1038\/nrmicro1208"},{"key":"680_CR4","doi-asserted-by":"publisher","unstructured":"Gupta D, Mohan S. Influenza vaccine: a review on current scenario and future prospects. J Genet Eng Biotechnol. 2023, Dec;21(1):1\u201310. https:\/\/doi.org\/10.1186\/S43141-023-00581-Y.","DOI":"10.1186\/S43141-023-00581-Y"},{"issue":"7","key":"680_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/14760584.2019.1639503","volume":"18","author":"CM Trombetta","year":"2019","unstructured":"Trombetta CM, Marchi S, Manini I, Lazzeri G, Montomoli E. Challenges in the development of egg-independent vaccines for influenza. Expert Rev Vaccines. 2019, Jul;18(7):737\u201350. https:\/\/doi.org\/10.1080\/14760584.2019.1639503.","journal-title":"Expert Rev Vaccines"},{"key":"680_CR6","doi-asserted-by":"publisher","unstructured":"Liang W, et al. Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution. PLoS Pathog. 2022, Sep;18(9):e1010875. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1010875.","DOI":"10.1371\/JOURNAL.PPAT.1010875"},{"issue":"12","key":"680_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/J.VACCINE.2019.01.086","volume":"37","author":"J Herrera-Rodriguez","year":"2019","unstructured":"Herrera-Rodriguez J, Signorazzi A, Holtrop M, de Vries-Idema J, Huckriede A. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production. Vaccine. 2019, Mar;37(12):1630\u201337. https:\/\/doi.org\/10.1016\/J.VACCINE.2019.01.086.","journal-title":"Vaccine"},{"issue":"1","key":"680_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-153","volume":"11","author":"AC Tricco","year":"2013","unstructured":"Tricco AC, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med. 2013, Jun;11(1):1\u201319. https:\/\/doi.org\/10.1186\/1741-7015-11-153.","journal-title":"BMC Med"},{"key":"680_CR9","unstructured":"Anderson RM, Scannon PJ, Matthews JT, Rappuoli R, Shaw A, Estell D. BRIDGE the planning for pandemics of infectious diseases Pharmaceutical preparedness for a pandemic egg-based production of influenza vaccine: 30 years of commercial experience cell-culture-based vaccine production: technological options alternative Methods of making influenza vaccines adapting industry practices for the rapid, Large-scale manufacture of Pharmaceutical proteins,\u201d 2006. [Online]. Available: https:\/\/www.nae.edu\/7398\/EngineeringandVaccineProductionforanInfluenzaPandemic."},{"issue":"3","key":"680_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/J.BIOLOGICALS.2009.02.014","volume":"37","author":"MMJ Cox","year":"2009","unstructured":"Cox MMJ, Hollister JR. FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals. 2009, Jun;37(3):182\u201389. https:\/\/doi.org\/10.1016\/J.BIOLOGICALS.2009.02.014.","journal-title":"Biologicals"},{"issue":"34","key":"680_CR11","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1016\/J.VACCINE.2013.06.034","volume":"31","author":"EAS Nelson","year":"2013","unstructured":"Nelson EAS, et al. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18\u201326 years. Vaccine. 2013, Jul;31(34):3452\u201360. https:\/\/doi.org\/10.1016\/J.VACCINE.2013.06.034.","journal-title":"Vaccine"},{"key":"680_CR12","doi-asserted-by":"publisher","unstructured":"Parums DV. Editorial: first approval of the protein-based adjuvanted Nuvaxovid (NVX-CoV2373) Novavax vaccine for SARS-CoV-2 could increase vaccine uptake and provide immune protection from viral variants. Med Sci Monit. 2022;28:e936523\u20131. https:\/\/doi.org\/10.12659\/MSM.936523.","DOI":"10.12659\/MSM.936523"},{"issue":"2\u20134","key":"680_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/J.VETMIC.2012.11.035","volume":"162","author":"JG Choi","year":"2013","unstructured":"Choi JG, et al. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens. Vet Microbiol. 2013, Mar;162(2\u20134):623\u201330. https:\/\/doi.org\/10.1016\/J.VETMIC.2012.11.035.","journal-title":"Vet Microbiol"},{"key":"680_CR14","doi-asserted-by":"publisher","unstructured":"Subathra M, Santhakumar P, Naidu SS, Narasu ML, Senthilkumar TMA, Lal SK. Expression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice. Appl Biochem Biotechnol. 2014, Feb;172(7):3635\u201345. https:\/\/doi.org\/10.1007\/S12010-014-0771-Z.","DOI":"10.1007\/S12010-014-0771-Z"},{"issue":"6","key":"680_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2183\/PJAB.88.226","volume":"88","author":"N Sriwilaijaroen","year":"2012","unstructured":"Sriwilaijaroen N, Suzuki Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc The Jpn Acad, Ser B. 2012, Jun;88(6):226\u201349. https:\/\/doi.org\/10.2183\/PJAB.88.226.","journal-title":"Proc The Jpn Acad, Ser B"},{"issue":"3","key":"680_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/07391102.2018.1436089","volume":"37","author":"LV Kordyukova","year":"2019","unstructured":"Kordyukova LV, Shtykova EV, Baratova LA, Svergun DI, Batishchev OV. Matrix proteins of enveloped viruses: a case study of influenza a virus M1 protein. J Biomol Struct Dyn. 2019, Feb;37(3):671\u201390. https:\/\/doi.org\/10.1080\/07391102.2018.1436089.","journal-title":"J Biomol Struct Dyn"},{"key":"680_CR17","doi-asserted-by":"publisher","unstructured":"Song J-M, et al. Influenza virus-like particles containing M2 induce broadly cross Protective immunity. PLoS One. 2011, Jan;6(1):e14538. https:\/\/doi.org\/10.1371\/journal.pone.0014538.","DOI":"10.1371\/journal.pone.0014538"},{"issue":"1","key":"680_CR18","doi-asserted-by":"publisher","first-page":"504831","DOI":"10.1155\/2015\/504831","volume":"2015","author":"E Mili\u00e1n","year":"2015","unstructured":"Mili\u00e1n E, Kamen AA. Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines. Biomed Res Int. 2015, Jan;2015(1):504831. https:\/\/doi.org\/10.1155\/2015\/504831.","journal-title":"Biomed Res Int"},{"issue":"4","key":"680_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/BIT.28925","volume":"122","author":"R Correia","year":"2025","unstructured":"Correia R, et al. Continuous production of influenza VLPs using IC-BEVS and Multi-stage bioreactors. Biotechnol Bioeng. 2025, Apr;122(4):846\u201357. https:\/\/doi.org\/10.1002\/BIT.28925.","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"680_CR20","doi-asserted-by":"publisher","first-page":"1903664","DOI":"10.1080\/19420862.2021.1903664","volume":"13","author":"O Khanal","year":"2021","unstructured":"Khanal O, Lenhoff AM. Developments and opportunities in continuous biopharmaceutical manufacturing. Mabs-austin. 2021;13(1):1903664. https:\/\/doi.org\/10.1080\/19420862.2021.1903664.","journal-title":"Mabs-austin"},{"issue":"8","key":"680_CR21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/bit.28118","volume":"119","author":"L Gerstweiler","year":"2022","unstructured":"Gerstweiler L, Billakanti J, Bi J, Middelberg APJ. An integrated and continuous downstream process for microbial virus-like particle vaccine biomanufacture. Biotechnol Bioeng. 2022, Aug;119(8):2122\u201333. https:\/\/doi.org\/10.1002\/bit.28118.","journal-title":"Biotechnol Bioeng"},{"key":"680_CR22","doi-asserted-by":"publisher","first-page":"102828","DOI":"10.1016\/J.COPBIO.2022.102828","volume":"78","author":"C Matanguihan","year":"2022","unstructured":"Matanguihan C, Wu P. Upstream continuous processing: recent advances in production of biopharmaceuticals and challenges in manufacturing. Curr Opin Biotechnol. 2022, Dec;78:102828. https:\/\/doi.org\/10.1016\/J.COPBIO.2022.102828.","journal-title":"Curr Opin Biotechnol"},{"key":"680_CR23","doi-asserted-by":"publisher","first-page":"118753","DOI":"10.1016\/J.SEPPUR.2021.118753","volume":"269","author":"DG Turpeinen","year":"2021","unstructured":"Turpeinen DG, et al. Continuous purification of an enveloped and non-enveloped viral particle using an aqueous two-phase system. Sep Purif Technol. 2021, Aug;269:118753. https:\/\/doi.org\/10.1016\/J.SEPPUR.2021.118753.","journal-title":"Sep Purif Technol"},{"key":"680_CR24","doi-asserted-by":"publisher","unstructured":"Nold NM, et al. Continuous purification of a parvovirus using two aqueous two-phase extraction steps. Biotechnol Prog. 2025, Sep;41(5). https:\/\/doi.org\/10.1002\/btpr.70034.","DOI":"10.1002\/btpr.70034"},{"issue":"17","key":"680_CR25","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1016\/j.vaccine.2011.01.081","volume":"29","author":"K Aggarwal","year":"2011","unstructured":"Aggarwal K, Jing F, Maranga L, Liu J. Bioprocess optimization for cell culture based influenza vaccine production. Vaccine. 2011, Apr;29(17):3320\u201328. https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.081.","journal-title":"Vaccine"},{"key":"680_CR26","doi-asserted-by":"publisher","unstructured":"Tapia F, Wohlfarth D, Sandig V, Jordan I, Genzel Y, Reichl U. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the \u2018von Magnus effect,\u2019\u201d. PLoS One. 2019, Nov;14(11):e0224317. https:\/\/doi.org\/10.1371\/journal.pone.0224317.","DOI":"10.1371\/journal.pone.0224317"},{"key":"680_CR27","doi-asserted-by":"publisher","unstructured":"Lai CC, et al. Process development for pandemic influenza VLP vaccine production using a baculovirus expression system. J Biol Eng. 2019, Oct;13(1):1\u20139. https:\/\/doi.org\/10.1186\/s13036-019-0206-z.","DOI":"10.1186\/s13036-019-0206-z"},{"key":"680_CR28","doi-asserted-by":"publisher","unstructured":"Krell PJ. Passage effect of virus infection in insect cells. Cytotechnology. 1996;20(1\u20133):125\u201337. https:\/\/doi.org\/10.1007\/BF00350393.","DOI":"10.1007\/BF00350393"},{"key":"680_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0065-3527(08)60529-1","volume-title":"Incomplete forms of influenza virus","author":"P von Magnus","year":"1954","unstructured":"von Magnus P. Incomplete forms of influenza virus. 1954. p. 59\u201379. https:\/\/doi.org\/10.1016\/S0065-3527(08)60529-1."},{"key":"680_CR30","doi-asserted-by":"publisher","unstructured":"Rold\u00e3o A, Vicente T, Peixoto C, Carrondo MJT, Alves PM. Quality control and analytical methods for baculovirus-based products. J Invertebr Pathol. 2011, Jul;107, no. SUPPL., pp. S94\u2013105. https:\/\/doi.org\/10.1016\/J.JIP.2011.05.009.","DOI":"10.1016\/J.JIP.2011.05.009"},{"issue":"2","key":"680_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1023\/A:1007970020274","volume":"24","author":"Y-C Hu","year":"1997","unstructured":"Hu Y-C, Wang M-Y, Bentley WE. A tubular segmented-flow bioreactor for the infection of insect cells with recombinant baculovirus. Cytotechnology. 1997;24(2):143\u201352. https:\/\/doi.org\/10.1023\/A:1007970020274.","journal-title":"Cytotechnology"},{"key":"680_CR32","unstructured":"Life Technologies Corporation, \u201cExpiSfTM Expression System USER GUIDE,\u201d 2018."},{"key":"680_CR33","doi-asserted-by":"publisher","first-page":"114495","DOI":"10.1016\/j.jviromet.2022.114495","volume":"303","author":"W Qingsheng","year":"2022","unstructured":"Qingsheng W, Yuanyuan L. Establishment, verification and application of rapid detection of baculovirus infectious titer by flow cytometry. J Virol Methods. 2022, May;303:114495. https:\/\/doi.org\/10.1016\/j.jviromet.2022.114495.","journal-title":"J Virol Methods"},{"key":"680_CR34","unstructured":"Bottino PJ. Gus Gene Assay in transformed tissues. https:\/\/goldbio.com\/documents\/1053\/Gus%20Gene%20Assay%20Protocol.pdf."},{"key":"680_CR35","unstructured":"\u201cab234625 \u03b2-glucuronidase activity assay kit (fluorometric). https:\/\/www.abcam.com\/en-us\/products\/assay-kits\/glucuronidase-activity-assay-kit-fluorometric-ab234625."},{"key":"680_CR36","doi-asserted-by":"publisher","unstructured":"Ladiwala P, et al. Unraveling cytotoxicity in HEK293 cells during recombinant AAV production for Gene therapy applications. Biotechnol J. 2025, Mar;20(3). https:\/\/doi.org\/10.1002\/biot.202400501.","DOI":"10.1002\/biot.202400501"},{"key":"680_CR37","unstructured":"Bio-Imaging S. Negative staining. http:\/\/web.path.ox.ac.uk\/%7Ebioimaging\/bitm\/instructions_and_information\/EM\/neg_stain.pdf."},{"issue":"7","key":"680_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012, Jul;9(7):671\u201375. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"680_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195171792.001.0001","volume-title":"Fitting models to biological data using linear and nonlinear regression","author":"H Motulsky","year":"2004","unstructured":"Motulsky H, Christopoulos A. Fitting models to biological data using linear and nonlinear regression. NY: Oxford University PressNew York; 2004. https:\/\/doi.org\/10.1093\/oso\/9780195171792.001.0001."},{"key":"680_CR40","unstructured":"Levenspiel O. Chemical reaction engineering\/Octave Levenspiel. Chem Reaction Eng\/. 2001. [Online]. Available: https:\/\/books.google.com\/books\/about\/Chemical_Reaction_Engineering.html?id=vw48EAAAQBAJ."},{"key":"680_CR41","doi-asserted-by":"publisher","first-page":"116188","DOI":"10.1016\/j.ces.2020.116188","volume":"230","author":"AE Rodrigues","year":"2021","unstructured":"Rodrigues AE. Residence time distribution (RTD) revisited. Chem Eng Sci. 2021, Feb;230:116188. https:\/\/doi.org\/10.1016\/j.ces.2020.116188.","journal-title":"Chem Eng Sci"},{"issue":"2","key":"680_CR42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/BIT.20521","volume":"91","author":"Y Voloshin","year":"2005","unstructured":"Voloshin Y, Lawal A, Panikov NS. Continuous plug-flow bioreactor: experimental testing with Pseudomonas putida culture grown on benzoate. Biotechnol Bioeng. 2005, Jul;91(2):254\u201359. https:\/\/doi.org\/10.1002\/BIT.20521.","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"680_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/bit.260430106","volume":"43","author":"K Trinh","year":"1994","unstructured":"Trinh K, Garcia-Briones M, Chalmers JJ, Hink F. Quantification of damage to suspended insect cells as a result of bubble rupture. Biotechnol Bioeng. 1994, Jan;43(1):37\u201345. https:\/\/doi.org\/10.1002\/bit.260430106.","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"680_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/bp00008a010","volume":"7","author":"JJ Chalmers","year":"1991","unstructured":"Chalmers JJ, Bavarian F. Microscopic visualization of insect cell-Bubble interactions. II: the Bubble film and Bubble rupture. Biotechnol Prog. 1991, Mar;7(2):151\u201358. https:\/\/doi.org\/10.1021\/bp00008a010.","journal-title":"Biotechnol Prog"},{"key":"680_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/978-1-4939-3043-2_23","volume":"1350","author":"HC Wu","year":"2016","unstructured":"Wu HC, Hu YC, Bentley WE. Tubular bioreactor for probing baculovirus infection and protein production. Methods Mol Biol. 2016, Jan;1350:461\u201367. https:\/\/doi.org\/10.1007\/978-1-4939-3043-2_23.","journal-title":"Methods Mol Biol"},{"key":"680_CR46","doi-asserted-by":"publisher","unstructured":"Muradoglu M, G\u00fcnther A, Stone HA. A computational study of axial dispersion in segmented gas-liquid flow. Phys Fluids. 2007, Jul;19(7). https:\/\/doi.org\/10.1063\/1.2750295.","DOI":"10.1063\/1.2750295"},{"issue":"1","key":"680_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1006\/viro.1994.1646","volume":"205","author":"DL Jarvis","year":"1994","unstructured":"Jarvis DL, Garcia A. Biosynthesis and processing of the Autographa californica nuclear polyhedrosis virus gp64 protein. Virology. 1994, Nov;205(1):300\u201313. https:\/\/doi.org\/10.1006\/viro.1994.1646.","journal-title":"Virology"},{"issue":"7","key":"680_CR48","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1128\/jvi.70.7.4607-4616.1996","volume":"70","author":"SA Monsma","year":"1996","unstructured":"Monsma SA, Oomens AG, Blissard GW. The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection. J Virol. 1996, Jul;70(7):4607\u201316. https:\/\/doi.org\/10.1128\/jvi.70.7.4607-4616.1996.","journal-title":"J Virol"},{"issue":"5","key":"680_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/(SICI)1097-0290(19970605)54:5<468:AID-BIT7>3.0.CO;2-C","volume":"54","author":"KU Dee","year":"1997","unstructured":"Dee KU, Shuler ML. A mathematical model of the trafficking of acid-dependent enveloped viruses: application to the binding, uptake, and nuclear accumulation of baculovirus. Biotechnol Bioeng. 1997, Jun;54(5):468\u201390. https:\/\/doi.org\/10.1002\/(SICI)1097-0290(19970605)54:5%26lt;468:AID-BIT7%26gt;3.0.CO;2-C.","journal-title":"Biotechnol Bioeng"},{"key":"680_CR50","doi-asserted-by":"publisher","unstructured":"Nielsen LK. Virus production from cell culture, kinetics. In: Encyclopedia of cell technology. Wiley; 2000. https:\/\/doi.org\/10.1002\/0471250570.spi106.","DOI":"10.1002\/0471250570.spi106"},{"issue":"1","key":"680_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.virol.2012.10.018","volume":"436","author":"YV Lyupina","year":"2013","unstructured":"Lyupina YV, Abaturova SB, Erokhov PA, Orlova OV, Beljelarskaya SN, Mikhailov VS. Proteotoxic stress induced by Autographa californica nucleopolyhedrovirus infection of Spodoptera frugiperda Sf9 cells. Virology. 2013, Feb;436(1):49\u201358. https:\/\/doi.org\/10.1016\/j.virol.2012.10.018.","journal-title":"Virology"},{"issue":"13","key":"680_CR52","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0024-3205(02)01917-3","volume":"71","author":"B Sperker","year":"2002","unstructured":"Sperker B, M\u00fcrdter TE, Backman JT, Fritz P, Kroemer HK. Expression of active human \u03b2-glucuronidase in Sf9 cells infected with recombinant baculovirus. Life Sci. 2002, Aug;71(13):1547\u201357. https:\/\/doi.org\/10.1016\/S0024-3205(02)01917-3.","journal-title":"Life Sci"},{"issue":"2","key":"680_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/J.BEJ.2008.01.008","volume":"40","author":"T Gotoh","year":"2008","unstructured":"Gotoh T, Fukuhara M, Kikuchi KI. Mathematical model for change in diameter distribution of baculovirus-infected Sf-9 insect cells. Biochem. Eng. J. 2008, Jun;40(2):379\u201386. https:\/\/doi.org\/10.1016\/J.BEJ.2008.01.008.","journal-title":"Biochem. Eng. J"},{"key":"680_CR54","doi-asserted-by":"publisher","unstructured":"Possee RD, Chambers AC, Graves LP, Aksular M, King LA. Recent Developments in the use of baculovirus expression vectors. Curr Issues Mol Biol. 2020;215\u201330. https:\/\/doi.org\/10.21775\/cimb.034.215.","DOI":"10.21775\/cimb.034.215"},{"issue":"16","key":"680_CR55","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/J.VACCINE.2018.02.106","volume":"36","author":"BJ Lindsay","year":"2018","unstructured":"Lindsay BJ, et al. Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy. Vaccine. 2018, Apr;36(16):2147\u201354. https:\/\/doi.org\/10.1016\/J.VACCINE.2018.02.106.","journal-title":"Vaccine"},{"issue":"6","key":"680_CR56","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/bit.260440607","volume":"44","author":"JF Power","year":"1994","unstructured":"Power JF, Reid S, Radford KM, Greenfield PF, Nielsen LK. Modeling and optimization of the baculovirus expression vector system in batch suspension culture. Biotechnol Bioeng. 1994, Sep;44(6):710\u201319. https:\/\/doi.org\/10.1002\/bit.260440607.","journal-title":"Biotechnol Bioeng"},{"key":"680_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.omtm.2023.05.019","volume":"30","author":"F Destro","year":"2023","unstructured":"Destro F, et al. Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system. Mol Ther Methods Clin Dev. 2023, Sep;30:122\u201346. https:\/\/doi.org\/10.1016\/j.omtm.2023.05.019.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"680_CR58","doi-asserted-by":"publisher","first-page":"107608","DOI":"10.1016\/j.biotechadv.2020.107608","volume":"44","author":"S Kiesslich","year":"2020","unstructured":"Kiesslich S, Kamen AA. Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnol Adv. 2020, Nov;44:107608. https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107608.","journal-title":"Biotechnol Adv"},{"key":"680_CR59","doi-asserted-by":"publisher","unstructured":"Ou J, et al. Scalable process development for rAAV transient transfection production using computational fluid dynamics modeling. Biotechnol Prog. 2025, Sep;41(5). https:\/\/doi.org\/10.1002\/btpr.70028.","DOI":"10.1002\/btpr.70028"},{"issue":"1","key":"680_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13036-021-00264-7","volume":"15","author":"OF Garcia-Aponte","year":"2021","unstructured":"Garcia-Aponte OF, Herwig C, Kozma B. Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy. J Biol Eng. 2021, Apr;15(1):13. https:\/\/doi.org\/10.1186\/s13036-021-00264-7.","journal-title":"J Biol Eng"},{"key":"680_CR61","doi-asserted-by":"publisher","first-page":"107660","DOI":"10.1016\/j.biotechadv.2020.107660","volume":"46","author":"G Nadal-Rey","year":"2021","unstructured":"Nadal-Rey G, McClure DD, Kavanagh JM, Cornelissen S, Fletcher DF, Gernaey KV. Understanding gradients in industrial bioreactors. Biotechnol Adv. 2021, Jan;46:107660. https:\/\/doi.org\/10.1016\/j.biotechadv.2020.107660.","journal-title":"Biotechnol Adv"},{"key":"680_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jbiotec.2015.04.026","volume":"213","author":"V Girard","year":"2015","unstructured":"Girard V, et al. Large-scale monoclonal antibody purification by continuous chromatography, from process design to scale-up. J Biotechnol. 2015, Nov;213:65\u201373. https:\/\/doi.org\/10.1016\/j.jbiotec.2015.04.026.","journal-title":"J Biotechnol"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-026-00680-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00680-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:28:53Z","timestamp":1780882133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13036-026-00680-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1186\/s13036-026-00680-7","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Completing interests"}}],"article-number":"98"}}